FDA Clears Biofourmis’ AI-Driven Arrhythmia Detection Platform RhythmAnalytics

By
Cathy Russey
-
Biofourmis arrhythmia detection RhythmAnalytics
Biofourmis, a Singapore-based health-tech startup, has received FDA clearance for its cloud-based software, RhythmAnalytics, which helps healthcare professionals in detecting cardiac arrhythmia, or irregular heartbeat. The cloud-based software uses enhanced […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleHands-on Developer Workshop in Helsinki by STMicroelectronics, Sigfox and Connected Finland
Next articleNanusens Surpasses £200,000 Funding Target, Nearing £350,000
Cathy Russey
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.

RELATED ARTICLESMORE FROM AUTHOR